⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5013799 | 1.00 | — | — | |
| SCHEMBL75408 | 0.72 | LMNA (0.44) | — | |
| SCHEMBL1270184 | 0.72 | LMNA (0.44) | — | |
| SCHEMBL11661082 | 0.70 | — | — | |
| SCHEMBL448417 | 0.69 | — | — | |
| SCHEMBL8581848 | 0.69 | — | — | |
| SCHEMBL27697564 | 0.69 | — | — | |
| SCHEMBL2050717 | 0.69 | — | — | |
| SCHEMBL10442883 | 0.67 | LMNA (0.38) | — | |
| SCHEMBL28858420 | 0.67 | LMNA (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115957145-B | Chewing effervescent tablet capable of self-providing nitric oxide and preparation method and application thereof | 南京诺令生物科技有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-116251166-A | Two-phase composition with antiviral effect and application thereof | 南京诺令生物科技有限公司 | 2023-06-13 | — | — | CN | claimed |
| CN-115957145-A | Chewable effervescent tablet capable of providing nitric oxide by itself and preparation method and application thereof | 南京诺令生物科技有限公司 | 2023-04-14 | — | — | CN | claimed |
| CN-115944584-A | Gel product for gynecology and preparation method and application thereof | 南京诺令生物科技有限公司 | 2023-04-11 | — | — | CN | claimed |
| CN-115634291-A | Preparation with effect of relieving diabetic foot pain and preparation method and application thereof | 南京诺令生物科技有限公司 | 2023-01-24 | — | — | CN | claimed |
| US-20190336602-A1 | STERILISATION OF S-NITROSOTHIOLS | Salupont Consulting Ltd. (GB) | 2019-11-07 | — | — | US | claimed |
| US-20180055932-A1 | STERILISATION OF S-NITROSOTHIOLS | Salupont Consulting Ltd. (GB) | 2018-03-01 | — | — | US | claimed |
| EP-0914348-A1 | POLYMERS FOR DELIVERING NITRIC OXIDE IN VIVO | DUKE UNIVERSITY MEDICAL CENTER (US) | 1999-05-12 | — | — | EP | claimed |
| US-5770645-A | THIOLATED NITROSYLATED POLYSACCHARIDE | DUKE UNIVERSITY MEDICAL CENTER (US) | 1998-06-23 | — | — | US | claimed |
| WO-1998005689-A1 | POLYMERS FOR DELIVERING NITRIC OXIDE IN VIVO | DUKE UNIVERSITY MEDICAL CENTER (US) | 1998-02-12 | — | — | WO | claimed |
| CN-115957145-B | Chewing effervescent tablet capable of self-providing nitric oxide and preparation method and application thereof | 南京诺令生物科技有限公司 | 2024-12-27 | — | — | CN | disclosed |
| US-20240269353-A1 | NITRIC OXIDE-RELEASING DEVICES | KNOW BIO LLC (US) | 2024-08-15 | — | — | US | disclosed |
| EP-4340612-A1 | NITRIC OXIDE-RELEASING DEVICES | KNOW Bio, LLC (US) | 2024-03-27 | — | — | EP | disclosed |
| EP-4233830-A2 | COMPOSITION FOR DELIVERING NITRIC OXIDE TO SKIN | Insense Limited (GB) | 2023-08-30 | — | — | EP | disclosed |
| EP-4233831-A2 | COMPOSITION FOR DELIVERING NITRIC OXIDE TO SKIN | Insense Limited (GB) | 2023-08-30 | — | — | EP | disclosed |
| US-20010000039-A1 | Stable NO-delivering compounds | TOONE ERIC J (US) | 2001-03-15 | — | — | US | disclosed |
| WO-1999067210-A1 | STABLE NO-DELIVERING COMPOUNDS | DUKE UNIVERSITY MEDICAL CENTER (US) | 1999-12-29 | — | — | WO | disclosed |
| EP-0914348-A1 | POLYMERS FOR DELIVERING NITRIC OXIDE IN VIVO | DUKE UNIVERSITY MEDICAL CENTER (US) | 1999-05-12 | — | — | EP | disclosed |
| US-5770645-A | THIOLATED NITROSYLATED POLYSACCHARIDE | DUKE UNIVERSITY MEDICAL CENTER (US) | 1998-06-23 | — | — | US | disclosed |
| WO-1998005689-A1 | POLYMERS FOR DELIVERING NITRIC OXIDE IN VIVO | DUKE UNIVERSITY MEDICAL CENTER (US) | 1998-02-12 | — | — | WO | disclosed |